Avances en uro-oncología «OncoForum»: lo mejor del 2019
- 15 September 2020
- journal article
- review article
- Published by Elsevier BV in Actas Españolas de Psiquiatría
- Vol. 44 (9), 586-596
- https://doi.org/10.1016/j.acuro.2020.06.007
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Avances en uro-oncología «OncoForum»: lo mejor del 2017Actas Españolas de Psiquiatría, 2018
- Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD TrialEuropean Urology, 2018
- Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell CarcinomaThe New England Journal of Medicine, 2018
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate CancerThe New England Journal of Medicine, 2018
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaThe New England Journal of Medicine, 2018
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trialThe Lancet, 2018
- Avances en uro-oncología «OncoForum»: lo mejor de 2015Actas Españolas de Psiquiatría, 2016
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trialThe Lancet, 2015
- Avances en uro-oncología «OncoForum»: lo mejor de 2014Actas Españolas de Psiquiatría, 2015
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015